Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Treatment of Parkinson´s disease by recreating the endogenous L-Dopa/Dopamine production in midbrain

Reference number
Coordinator PARKCELL AB
Funding from Vinnova SEK 2 000 000
Project duration March 2014 - March 2016
Status Completed

External links

Last updated 25 November 2019

Reference number 2014-01159

Page statistics